Insider Selling: Danaher Co. (NYSE:DHR) SVP Sells $1,000,040.00 in Stock

Danaher Co. (NYSE:DHR) SVP Brian W. Ellis sold 4,000 shares of the stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $250.01, for a total transaction of $1,000,040.00. Following the transaction, the senior vice president now owns 29,830 shares in the company, valued at $7,457,798.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Danaher Trading Up 0.3 %

NYSE DHR opened at $246.58 on Friday. The company has a fifty day simple moving average of $248.87 and a two-hundred day simple moving average of $231.16. The stock has a market cap of $182.64 billion, a P/E ratio of 41.79, a P/E/G ratio of 3.78 and a beta of 0.83. Danaher Co. has a 12-month low of $182.09 and a 12-month high of $259.00. The company has a current ratio of 1.85, a quick ratio of 1.37 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.20. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.62 billion. During the same quarter last year, the company posted $2.36 earnings per share. The firm’s revenue was down 2.6% compared to the same quarter last year. On average, analysts forecast that Danaher Co. will post 7.65 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 26th. Investors of record on Thursday, March 28th were issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. The ex-dividend date of this dividend was Wednesday, March 27th. This is a boost from Danaher’s previous quarterly dividend of $0.24. Danaher’s dividend payout ratio (DPR) is 18.31%.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the business. Riverwater Partners LLC raised its holdings in shares of Danaher by 58.9% during the first quarter. Riverwater Partners LLC now owns 3,571 shares of the conglomerate’s stock worth $892,000 after purchasing an additional 1,323 shares during the last quarter. James Hambro & Partners raised its holdings in shares of Danaher by 9.8% during the first quarter. James Hambro & Partners now owns 250,443 shares of the conglomerate’s stock worth $62,493,000 after purchasing an additional 22,438 shares during the last quarter. Conning Inc. increased its holdings in Danaher by 1.3% in the first quarter. Conning Inc. now owns 22,930 shares of the conglomerate’s stock valued at $5,726,000 after buying an additional 292 shares in the last quarter. K.J. Harrison & Partners Inc increased its holdings in Danaher by 20.8% in the first quarter. K.J. Harrison & Partners Inc now owns 11,820 shares of the conglomerate’s stock valued at $2,952,000 after buying an additional 2,034 shares in the last quarter. Finally, McGuire Investment Group LLC increased its holdings in Danaher by 0.8% in the first quarter. McGuire Investment Group LLC now owns 34,962 shares of the conglomerate’s stock valued at $8,731,000 after buying an additional 294 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on DHR. Barclays increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “equal weight” rating in a research note on Wednesday. TD Cowen raised their target price on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research note on Wednesday. Citigroup raised their target price on shares of Danaher from $280.00 to $290.00 and gave the company a “buy” rating in a research note on Wednesday. Bank of America raised their target price on shares of Danaher from $258.00 to $270.00 and gave the company a “neutral” rating in a research note on Wednesday. Finally, Raymond James raised their target price on shares of Danaher from $240.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Six equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $269.64.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.